Emerphed Injection
NDC Package 14789-250-10

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Emerphed (ephedrine sulfate) injection is eMERPHED is indicated for the treatment of clinically important hypotension occurring in the setting of anesthesia. This formulation utilizes a injection delivery system. Marketed by Nexus Pharamaceuticals Inc., this product is identified by NDC 14789-250 and is authorized under FDA application NDA213407.

Identification & Billing

NDC Package Code
14789-250-10
Package Description
10 VIAL in 1 CARTON / 10 mL in 1 VIAL (14789-250-07)
Product Code
14789-250
11-Digit Billing Format
14789025010
Billing Unit
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Emerphed
Non-Proprietary Name
Ephedrine Sulfate
Substance Name
Ephedrine Sulfate
Dosage Form
Injection - A sterile preparation intended for parenteral use; five distinct classes of injections exist as defined by the USP.
Administration Route
Intravenous - Administration within or into a vein or veins.
Active Ingredient(s)
EPHEDRINE SULFATE 5 mg/mL
Pharmacologic Class
Usage Information
EMERPHED is indicated for the treatment of clinically important hypotension occurring in the setting of anesthesia.

Regulatory & Marketing

Labeler Name
Nexus Pharamaceuticals Inc.
Product Type
Human Prescription Drug
FDA Application #
NDA213407
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
05-15-2020
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 14789-250-10 identifies a specific commercial package of 10 vial in 1 carton / 10 ml in 1 vial (14789-250-07) of Emerphed, a human prescription drug labeled by Nexus Pharamaceuticals Inc.. This injection is formulated for intravenous use and contains ephedrine sulfate as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Nexus Pharamaceuticals Inc. on May 15, 2020. The current certification is valid through December 31, 2026.

How is this Nexus Pharamaceuticals Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 14789025010. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
14789-250-10
11-Digit CMS (5-4-2)
14789-0250-10

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.